data + articles · 1 listed
newest 2012spec sheet11 rows
N-Phenethyl dimethylamine, chemically N,N-dimethylphenethylamine, is a doubly methylated analogue of the trace amine beta-phenylethylamine that is widely marketed as an Eria jarensis extract in pre-workout and fat-burner supplements [1]. It is promoted as a euphoric stimulant that lifts mood, energy and focus, and rose to popularity as a purported replacement for the banned stimulant DMAA. Its promotional mechanism centers on trace-amine and adrenergic signaling, but rigorous human research on the compound is very limited.
- Reported euphoric, mood-forward stimulation popular in pre-workout formulas
- Perceived increase in energy, drive and focus with a smoother feel than harsher stimulants
- Increased heart rate and blood pressure
- Jitteriness or anxiety
- Headache
- Insomnia
Overview
N,N-dimethylphenethylamine is the N,N-dimethyl homologue of phenethylamine and belongs to the broader trace-amine family whose members interact with trace amine-associated receptor 1 (TAAR1) and modulate dopamine and norepinephrine neurotransmission [1]. Supplement marketing links it to the orchid Eria jarensis, though the practical ingredient is typically synthesized and supplied as a citrate or hydrochloride salt. Users report a smooth increase in mood, drive and alertness, and the ingredient became common after regulatory action removed DMAA from the market.
Despite its popularity, the scientific evidence base specific to N,N-dimethylphenethylamine is thin. There are essentially no controlled human trials establishing efficacy, dosing or safety, and much of the rationale is extrapolated from general phenethylamine and trace-amine pharmacology. As with plain phenethylamine, N-methylation patterns influence metabolism and duration, and the compound should be treated as an unproven stimulant supplement ingredient rather than a validated therapeutic.
- The ingredient is sold as Eria jarensis orchid extract, but the compound in most products is understood to be synthesized rather than botanically extracted.
- It gained traction specifically as a substitute after DMAA was pulled from the supplement market.
Mechanism
N,N-dimethylphenethylamine is thought to act, like other phenethylamine trace amines, through TAAR1 agonism and by promoting catecholamine ( and ) signaling, producing stimulation and mood elevation [1]. The two N-methyl groups distinguish it from parent phenethylamine and may modestly alter its interaction with monoamine oxidase and its duration of action, though detailed pharmacokinetic characterization in humans is lacking.
receptor fingerprint
TAAR1 (trace amine-associated receptor 1)Agonist (by analogy to phenethylamines)
and signalingCatecholamine modulation
Dosingtypical ranges, not medical advice
interested in protocols and clinical dosages? make an account to see them! ^_^
Safetyrisks and cautions, not medical advice
N-Phenethyl dimethylamine is a stimulant with limited safety data. Expected effects include increased heart rate and blood pressure, jitteriness, anxiety, headache and insomnia, and it should not be combined with monoamine oxidase inhibitors. Its regulatory status as a dietary ingredient is contested in several markets, and product labeling as a botanical extract can obscure the true synthetic content and dose. People with cardiovascular conditions, or who are pregnant or breastfeeding, should avoid it, and it is not an approved medicine.
History
N,N-dimethylphenethylamine entered the sports-supplement market in the mid-2010s, marketed as Eria jarensis extract and positioned as a legal-feeling alternative to DMAA and other banned stimulants. It became a staple stimulant in many pre-workouts and fat burners, valued for a euphoric, mood-forward energy, even as questions persisted about the accuracy of its botanical sourcing claims.
Reputation
Among pre-workout users, N-phenethyl dimethylamine has a favorable reputation for a pleasant, mood-lifting stimulation that feels smoother than harsher stimulants, and it is frequently blended with caffeine and other trace amines. Scientifically it is regarded skeptically because efficacy and safety data are sparse and its marketing as a natural extract is widely viewed as questionable.
Subjective profileweighing the evidence above
Sold as a botanical extract, but what is really in the tub is a synthetic stimulant with almost no human research behind it and contested regulatory standing. The kick is real and so are the raised heart rate, blood pressure and jitters. Caffeine gets you most of the way with far more known about it.
Resources
This entry is here for reference.
Research
- 1.Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine.
1 listed here; entry last updated July 2026
Reviews
My notesprivate to this device
FAQ
Is Eria jarensis extract the same as N-phenethyl dimethylamine?
Yes, N-phenethyl dimethylamine (N,N-dimethylphenethylamine) is the active compound sold under the Eria jarensis name, though in most products it is synthesized rather than genuinely extracted from the orchid.
Is it a proven or approved ingredient?
No. It is an unproven stimulant supplement ingredient with very limited human research, and its status as a legal dietary ingredient is disputed in several markets.
Adverse effects
- Increased heart rate and blood pressure
- Jitteriness or anxiety
- Headache
- Insomnia
Notes and cautions
- Unsafe combined with MAOIs